Schumacher Hardy, Böckler Dittmar, Bardenheuer Hubert, Hansmann Jochen, Allenberg Jens-Rainer
Department of Vascular and Endovascular Surgery, Ruprecht-Karls University Heidelberg, Germany.
J Endovasc Ther. 2003 Dec;10(6):1066-74. doi: 10.1177/152660280301000607.
To report our initial experience with total and subtotal endovascular aortic arch reconstruction combined with supra-aortic vessel transposition in high-risk patients and to present a new morphological classification of thoracic aortic lesions for patient and procedure selection.
Among 80 patients treated with thoracic stent-grafts at our department between 1997 and 2003, 8 patients (6 men; mean age 71 years, range 45-81) unfit for open repair were not candidates for standard endovascular repair due to inadequate proximal landing zones on the aortic arch. Commercially available endografts (Excluder, Zenith, Endofit, Talent) were used to repair the arch after supra-aortic vessel transposition was performed. The endograft was implanted transfemorally or via an iliac Dacron conduit graft with standardized endovascular techniques and deployed during intravenous adenosine-induced asystole. The imaging data from all thoracic endograft patients was analyzed to classify thoracic and thoracoabdominal lesions according to a 4-level anatomical system.
Deployment success was 100% after staged supra-aortic vessel transposition, but 1 patient died of endograft-related rupture of the proximal aortic arch. There was no neurological complication. Mean follow-up was 16 months (range 1-36). Patency of all endografts and conventional bypasses was 100%, and no migration was observed. One minor type II endoleak was demonstrated.
Initial results are encouraging for endovascular aortic arch repair in combination with supra-aortic transposition in selected high-risk patients with complex aortic pathologies.
报告我们在高危患者中进行全主动脉弓和部分主动脉弓血管腔内重建联合主动脉弓上血管转位的初步经验,并提出一种新的胸主动脉病变形态学分类方法,以用于患者选择和手术方案制定。
1997年至2003年间,在我们科室接受胸主动脉覆膜支架治疗的80例患者中,有8例(6例男性;平均年龄71岁,范围45 - 81岁)因身体状况不适宜接受开放手术修复,且由于主动脉弓近端锚定区不足而不适合标准的血管腔内修复。在进行主动脉弓上血管转位后,使用市售的腔内移植物(Excluder、Zenith、Endofit、Talent)修复主动脉弓。通过标准化的血管腔内技术,经股动脉或通过髂部涤纶人工血管将腔内移植物植入,并在静脉注射腺苷诱导心脏停搏期间展开。分析所有胸主动脉腔内移植物患者的影像数据,根据一个四级解剖系统对胸主动脉和胸腹主动脉病变进行分类。
分期进行主动脉弓上血管转位后,移植物展开成功率为100%,但有1例患者死于与腔内移植物相关的主动脉弓近端破裂。无神经并发症。平均随访时间为16个月(范围1 - 36个月)。所有腔内移植物和传统旁路血管均保持通畅,未观察到移位。发现1例轻微的II型内漏。
对于选定的患有复杂主动脉病变的高危患者,血管腔内主动脉弓修复联合主动脉弓上血管转位的初步结果令人鼓舞。